Back to Trades
Sell4
Entrada Therapeutics, Inc.
TRDA
Total Value
$282.2K
Net $230.0K sold
Sales
$230.0K
1 transaction
Company Information
- Company Name
- Entrada Therapeutics, Inc.
- Ticker Symbol
- TRDA
- CIK
- 0001689375
Insider Information
- Name
- Dowden Nathan J
- Role
- President & COO
- Location
- BOSTON, MA
Officer
Filing Details
- Filing Date
- May 4, 2026
- Transaction Date
- May 4, 2026
- Accession Number
- 0001873392-26-000004
- Form Type
- 4
- Net Trading Amount
- -$230.0K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | 15,000 | $1.74 | Exercise | $26.1K |
| May 4, 2026 | Common Stock | 15,000 | $15.33 | Sale | $230.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Derivative | 15,000 | $1.74 | Exercise | $26.1K |
Footnotes
- (F1)The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2025.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F3)The shares subject to this option fully vested on November 4, 2023.